| 臺北醫學大學 |
2006 |
Anti-angiogenesis mediated by angiostatin K1-3, K1-4 and K1-4.5. Involvement of p53, FasL, AKT and mRNA deregulation
|
吳銘斌; Chen YH; Wu HL; Li C; Huang YH; Chiang CW; Wu MP; Wu LW |
| 臺北醫學大學 |
2006 |
Anti-angiogenesis mediated by angiostatin K1–3, K1–4 and K1– 4.5
|
Ya-Huey Chen;Hua-Lin Wu;Ching Li;Yi-Hsien Huang;Chi-Wu Chiang;Ming-Ping Wu;Li-Wha Wu;吳銘斌 |
| 國立成功大學 |
2006-04 |
Anti-angiogenesis mediated by angiostatin Kl-3, Kl-4 and Kl-4.5 - Involvement of p53, FasL, AKT and mRNA deregulation
|
Chen, Ya-Huey; Wu, Hua-Lin; Li, Ching; Huang, Yi-Hsien; Chiang, Chi-Wu; Wu, Ming-Ping; Wu, Li-Wha |
| 國家衛生研究院 |
2008-11-28 |
Anti-angiogenic action of 5,5-diphenyl-2-thiohydantoin-N10 (DPTH-N10)
|
Liu, Y;Wu, J;Ho, PY;Chen, LC;Chen, CT;Liang, YC;Cheng, CK;Lee, WS |
| 臺北醫學大學 |
2008 |
Anti-angiogenic action of 5; 5-diphenyl-2-thiohydantoin-N10 (DPTH-N10).
|
李文森; Liu Y; Wu J; Ho PY; Chen LC; Chen JT; Liang YC; Cheng CK; Lee WS |
| 臺北醫學大學 |
2008 |
Anti-angiogenic action of 5; 5-diphenyl-2-thiohydantoin-N10 (DPTH-N10).
|
梁有志; Liu Y; Wu J; Ho PY; Chen LC; Chen CT; Liang YC; Cheng CK; Lee WS. |
| 輔英科技大學 |
2017-06-01 |
Anti-angiogenic effect of hexahydrocurcumin in rat corneal neovascularization
|
CN, Kuo;CH, Chen;SN, Chen;JC, Huang;LJ, Lai;CH, Lai;CH, Hung;CH, Lee;CY, Chen |
| 輔英科技大學 |
2018-07-01 |
Anti-angiogenic effect of hexahydrocurcumin in rat corneal neovascularization
|
陳中一 |
| 國立臺灣大學 |
2011 |
Anti-Angiogenic Effects and Mechanism of Prazosin
|
廖俊厚; 顧記華; 闕士傑; 余宏政; LIAO, CHUN-HOU; GUH, JIH-HWA; CHUEH, SHIH-CHIEH; YU, HONG-JENG |
| 臺大學術典藏 |
2021-02-02T00:43:15Z |
Anti-angiogenic effects and mechanism of prazosin
|
Liao C.-H.; Guh J.-H.; Chueh S.-C.; HONG-JENG YU |
| 臺大學術典藏 |
2021-06-02T05:43:49Z |
Anti-angiogenic effects and mechanism of prazosin
|
Liao C.-H.; JIH-HWA GUH; Chueh S.-C.; Yu H.-J. |
| 臺大學術典藏 |
2021-08-02T02:32:41Z |
Anti-angiogenic effects and mechanism of prazosin
|
Liao C.-H.; Guh J.-H.; SHIH-CHIEH CHUEH; Yu H.-J. |
| 亞洲大學 |
2008-11 |
Anti-Angiogenic effects of lycopene and the mechanism of its action.
|
黃晉修;Huang, Chin-Shiu |
| 亞洲大學 |
2008.11 |
Anti-Angiogenic effects of lycopene and the mechanism of its action.
|
黃晉修;Huang, Chin-Shiu |
| 亞洲大學 |
2012-06 |
Anti-angiogenic effects of lycopene through immunomodualtion of cytokine secretion in human peripheral blood mononuclear cells
|
黃晉修;Huang, Chin-Shiu |
| 臺北醫學大學 |
2005 |
Anti-angiogenic Effects of Tubulin-Interacting Agents.
|
黃玲玲; Tung ; F.-F.; Wang; H.-S.; Chen; C.-T.; Hwang; L.-L.; ; |
| 中國醫藥大學 |
2015-11 |
Anti-angiogenic properties of coenzyme Q0 through downregulation of MMP-9/NF-kB and upregulation of HO-1 signaling in TNF-a-activated human endothelial cells
|
楊新玲(Yang Hsin-ling);(Mallikarjuna Korivi);林明緯(Ming-Wei Lin);(Ssu-Ching Chen);(Chih-Wei Chou);許游章(You-Cheng Hseu)* |
| 亞洲大學 |
2015-11 |
Anti-angiogenic Properties of Coenzyme Q0 through Downregulation of MMP-9/NF-κB and Upregulation of HO-1 Signaling in TNF-α-activated Human Endothelial Cells
|
Hsin-Ling, Ya；Hsin-Ling Yang；Mallikarjuna；Mallikarjuna Korivi；Ming-Wei Lin；Ming-Wei Lin；Ssu-Ching Ch；Ssu-Ching Chen；Chih-Wei Cho；Chih-Wei Chou；許游章；Hseu You-Cheng |
| 亞洲大學 |
2015-11 |
Anti-angiogenic Properties of Coenzyme Q0 through Downregulation of MMP-9/NF-κB and Upregulation of HO-1 Signaling in TNF-α-activated Human Endothelial Cells
|
Yang), Hsin-Ling Ya(Hsin-Ling;Korivi), Mallikarjuna(Mallikarjuna;Lin), Ming-Wei Lin(Ming-Wei;Chen), Ssu-Ching Ch(Ssu-Ching;Chou), Chih-Wei Cho(Chih-Wei;許游章(Hseu, You-Cheng) |
| 國家衛生研究院 |
2017-10 |
Anti-angiogenic therapy in patients with advanced gastric and gastroesophageal junction cancer: A systematic review
|
Chen, LT;Oh, DY;Ryu, MH;Yeh, KH;Yeo, W;Carlesi, R;Cheng, R;Kim, J;Orlando, M;Kang, YK |
| 臺大學術典藏 |
2021-01-28T01:06:25Z |
Anti-angiogenic therapy in patients with advanced gastric and gastroesophageal junction cancer: A systematic review
|
Chen L.-T.;Oh D.-Y.;Ryu M.-H.;Kun-Huei Yeh;Yeo W.;Carlesi R.;Cheng R.;Kim J.;Orlando M.;Kang Y.-K.; Chen L.-T.; Oh D.-Y.; Ryu M.-H.; KUN-HUEI YEH; Yeo W.; Carlesi R.; Cheng R.; Kim J.; Orlando M.; Kang Y.-K. |
| 臺大學術典藏 |
2020-06-19T02:27:14Z |
Anti-angiogenic therapy renders large tumors vulnerable to immunotherapy via reducing immunosuppression in the tumor microenvironment
|
Chan S.-F.;Wang H.-T.;Kai-Wen Huang;Torng P.-L.;Lee H.-I.;Hwang L.-H.; Chan S.-F.; Wang H.-T.; KAI-WEN HUANG; Torng P.-L.; Lee H.-I.; Hwang L.-H. |
| 臺大學術典藏 |
2020-02-27T06:39:20Z |
Anti-angiogenic treatment (Bevacizumab) improves the responsiveness of photodynamic therapy in colorectal cancer
|
Peng C.-L.;Lin H.-C.;Chiang W.-L.;Shih Y.-H.;Chiang P.-F.;Luo T.-Y.;Cheng C.-C.;Ming-Jium Shieh; Peng C.-L.; Lin H.-C.; Chiang W.-L.; Shih Y.-H.; Chiang P.-F.; Luo T.-Y.; Cheng C.-C.; MING-JIUM SHIEH |
| 臺大學術典藏 |
2014 |
Anti-anxiety drugs use and cardiovascular outcomes in patients with myocardial infarction: A national wide assessment
|
Chiang F.-T.; Hwang J.-J.; Wu C.-K.; Huang Y.-T.; Lee J.-K.; Jimmy JYH-MING JIMMY JUANG; Tsai C.-T.; Lai L.-P.; Lin J.-L.; Chen P.-C.; Lin L.-Y. |
| 臺大學術典藏 |
2022-03-07T07:05:44Z |
Anti-anxiety drugs use and cardiovascular outcomes in patients with myocardial infarction: A national wide assessment
|
Wu C.-K.; Huang Y.-T.; JEN-KUANG LEE; Jimmy Juang J.-M.; Tsai C.-T.; Lai L.-P.; Hwang J.-J.; Chiang F.-T.; Lin J.-L.; Chen P.-C.; Lin L.-Y. |
